Getting started
Section 1 of 15Learning Objectives
Learning Objectives
Section: Learning Objectives
Each objective below describes a transfusion-service laboratory competency, product integrity, labeling, storage, and issue practice first; clinical treatment protocols second.
- Differentiate plasma derivatives (albumin, immune globulin, clotting-factor concentrates) from primary blood-bank components by manufacturing process and typical distribution pathway
- Describe the laboratory's receipt, storage-verification, and issue-documentation role for plasma derivatives that pass through the transfusion service, distinct from clinician- or pharmacy-directed product selection and dosing
- Explain why manufactured, pooled, virally-inactivated derivatives carry a different risk and regulatory profile than single-donor components, and hedge exact formulary/storage specifics to package insert and institutional SOP
